CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +126.92 | $63.95 | $8K | 5,090.67 |
| 2023-06-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +527.76 | $63.95 | $34K | 44,999.59 |
| 2023-06-03 | Lenkowsky Adam EVP, Chief Commercial Officer | Option exercise | +1,077 | 1,077 | ||
| 2023-06-03 | Lenkowsky Adam EVP, Chief Commercial Officer | Shares withheld for taxes | −551 | $65.66 | $36K | 526 |
| 2023-06-03 | Lenkowsky Adam EVP, Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,077 | 0 | ||
| 2023-05-03 | VESSEY RUPERT EVP & President, Research | Sale | −50,385 | $67.06 | $3.4M | 47,751 |
| 2023-05-02 | Greenlees Sharon SVP & Controller | Option exercise | +689 | 689 | ||
| 2023-05-02 | Greenlees Sharon SVP & Controller | Other disposition | −62 | 627 | ||
| 2023-05-02 | Greenlees Sharon SVP & Controller | Shares withheld for taxes | −227 | $68.10 | $15K | 400 |
| 2023-05-02 | Greenlees Sharon SVP & Controller | Option exercise | +328 | 728 | ||
| 2023-05-02 | Greenlees Sharon SVP & Controller | Shares withheld for taxes | −119 | $68.10 | $8K | 609 |
| 2023-05-02 | Greenlees Sharon SVP & Controller | Option exercise · Market Share Units | −689 | 2,067 | ||
| 2023-05-02 | Greenlees Sharon SVP & Controller | Option exercise · Restricted Stock Units | −328 | 984 | ||
| 2023-05-01 | Lenkowsky Adam EVP, Chief Commercial Officer | Grant or award · Market Share Units | +5,494 | 5,494 | ||
| 2023-05-01 | Lenkowsky Adam EVP, Chief Commercial Officer | Grant or award · Performance Shares | +8,241 | 8,241 | ||
| 2023-04-01 | Mily Elizabeth EVP, Strategy & BD | Option exercise | +3,662 | 34,058 | ||
| 2023-04-01 | Mily Elizabeth EVP, Strategy & BD | Other acquisition | +1,190 | 35,248 | ||
| 2023-04-01 | Mily Elizabeth EVP, Strategy & BD | Shares withheld for taxes | −2,059 | $69.31 | $143K | 33,189 |
| 2023-04-01 | Mily Elizabeth EVP, Strategy & BD | Option exercise | +2,684 | 35,873 | ||
| 2023-04-01 | Mily Elizabeth EVP, Strategy & BD | Shares withheld for taxes | −1,139 | $69.31 | $79K | 34,734 |
Page 42 of 56 · 1,112 trades